Is SEP or JNJ a better dividend investment in 2026?

SEP currently yields 5.65% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SEP offers higher current income.

What is the dividend yield difference between SEP and JNJ?

SEP has a forward dividend yield of 5.65% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2.29 percentage points.

Home › Compare › SEP vs JNJ

SEP vs JNJ: Dividend Comparison 2026

SEP yields 5.65% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SEP wins by $166.56M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SEP

● Live price

5.65%

Share price

$35.40

Annual div

$2.00

5Y div CAGR

78.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$166.58M

Annual income

$150,771,589.24

Full SEP calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SEP vs JNJ

📍 SEP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SEP	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SEP + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SEP pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SEP

Annual income on $10K today (after 15% tax)

$480.23/yr

After 10yr DRIP, annual income (after tax)

$128,155,850.85/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SEP beats the other by $128,155,147.24/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SEP + JNJ for your $10,000?

SEP: 50%JNJ: 50%

100% JNJ50/50100% SEP

Portfolio after 10yr

$83.30M

Annual income

$75,386,208.51/yr

Blended yield

90.50%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SEP

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SEP buys

JNJ buys

No recent congressional trades found for SEP or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSEPJNJ

Forward yield	5.65% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	78.7% ✓	5.8%
Portfolio after 10y	$166.58M ✓	$20.0K
Annual income after 10y	$150,771,589.24 ✓	$827.78
Total dividends collected	$165.34M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SEP vs JNJ ($10,000, DRIP)

Year	SEP Portfolio	SEP Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,710	$1,009.60	$10,676	$355.77	+$1.0K → SEP
2	$14,504	$1,974.40	$11,407	$389.39	+$3.1K → SEP
3	$19,603	$4,084.24	$12,198	$426.53	+$7.4K → SEP
4	$30,195	$9,219.34	$13,056	$467.62	+$17.1K → SEP
5	$56,025	$23,716.22	$13,987	$513.12	+$42.0K → SEP
6	$133,437	$73,490.93	$14,998	$563.56	+$118.4K → SEP
7	$435,108	$292,329.68	$16,098	$619.52	+$419.0K → SEP
8	$2,057,529	$1,591,964.07	$17,295	$681.69	+$2.04M → SEP
9	$14,774,108	$12,572,552.15	$18,599	$750.82	+$14.76M → SEP
10	$166,579,885	$150,771,589.24	$20,022	$827.78	+$166.56M → SEP

SEP vs JNJ: Complete Analysis 2026

SEP — Stock

SEP is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in SEP shares.

Full SEP Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SEP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SEP vs SCHD SEP vs JEPI SEP vs O SEP vs KO SEP vs MAIN SEP vs ABBV SEP vs MRK SEP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.